WASHINGTON, D.C. (WIAT/CNN) — Saturday, the U.S. Food and Drug Administration issued the first rapid diagnostic test that could detect coronavirus in less than an hour.
The authorization was made Friday and tests will begin shipping next week, according to a statement from California-based Cepheid, the company manufacturing the tests.
“Our dedicated team at the FDA has been working nonstop to expedite the review and authorization of novel diagnostics during the COVID-19 public health emergency,” said FDA Commissioner Stephen Hahn, M.D. “Today marks an important step in expanding the availability of testing and, importantly, rapid results. Point-of-care testing means that results are delivered to patients in the patient care settings, like hospitals, urgent care centers and emergency rooms, instead of samples being sent to a laboratory. With today’s authorization, there is now an option for testing at the point of care, which enables patient access to more immediate results.”
The company intends to roll-out availability of its point-of-care testing by March 30.
This story is breaking and will be updated.
- Patriots look to rebound as they host 2-0 Raiders
- LSU CB Derek Stingley, Jr. hospitalized, expected to be released
- Last-second field goal lifts Cajuns to first 3-0 start since 1988
- CDC ranks Halloween activities by COVID-19 risk: No trick-or-treating, crowded parties or indoor haunted houses
- ‘I have nothing left’: Sentimental items stolen from 90-year-old man while preparing to evacuate wildfire